Haleon (HLN) DIvidends Date & History

Key Takeaways

• Haleon plc offers a forward dividend yield of approximately 2%, paid semi-annually.
• The company targets a payout ratio of around 30% of adjusted earnings, with recent ratios near 38%, indicating sustainability.
• Dividends have shown consistent growth since the 2022 spin-off, with total annual payouts rising from about $0.10 per ADS in 2023 to $0.18 in 2025.
• Free cash flow comfortably covers dividends, with an FCF payout ratio of around 28%.
• HLN's yield is competitive with consumer health peers like Colgate-Palmolive (CL) and Procter & Gamble (PG).
• Recent ex-dividend date was April 10, 2026, with payment on May 14, 2026, at $0.12373 per share.

Dividend Overview

Haleon plc (HLN), the world's largest dedicated consumer health company, maintains a progressive dividend policy balancing growth investments and shareholder returns. The forward annual dividend is $0.19 per American Depositary Share (ADS), delivering a yield of about 1.99% at recent prices around $9.58. Payments occur semi-annually: an interim dividend after half-year results and a larger final dividend post-annual results, subject to approval. This profile positions HLN as a modest-yield dividend stock rather than a high-yield or aggressive growth play, appealing to investors seeking stability in the consumer staples sector. The policy targets a payout of approximately 30% of adjusted earnings, supporting long-term sustainability while funding brand innovation in oral care, pain relief, and digestive health.

Dividend History and Growth

Since its 2022 spin-off from GSK, Haleon has built a consistent dividend track record with semi-annual payments showing upward trends. For ADS holders, the 2023 total was roughly $0.1016 ($0.05773 final + $0.04387 interim), rising to $0.15799 in 2024 ($0.10527 + $0.05272), and $0.18137 in 2025 ($0.12459 + $0.05678). The 2025 final dividend of $0.12373 was declared ex April 10, 2026. On ordinary shares, payouts have increased annually: 2022 final at 2.4p, 2023 total 6.0p, 2024 total 6.6p, 2025 total 7.1p (interim 2.2p, final 4.9p). No cuts have occurred, reflecting a strategy to grow dividends at least in line with adjusted earnings growth, though the short history precludes a formal growth streak designation.

Dividend Sustainability and Payout Ratio

Haleon's dividend appears highly sustainable, underpinned by a targeted payout ratio of ~30% of adjusted earnings, with 2025 at approximately 38%. Trailing payout ratios range from 37% per Yahoo Finance data, well below levels signaling risk. Free cash flow (FCF) provides ample coverage, with an FCF dividend payout ratio of 27.56% for 2025, supported by £1.9 billion in FCF that year. Leverage reduction and robust cash generation from powerhouse brands like Sensodyne and Centrum further bolster stability. Earnings coverage remains strong, with no material debt concerns impacting distributions.

Dividend Compared to Industry Peers

In the consumer health and personal care sector, HLN's ~2% yield aligns closely with peers. Colgate-Palmolive (CL) offers around 2%, Procter & Gamble (PG) about 2.4%, and Kimberly-Clark (KMB) a higher 3.4%. Reckitt Benckiser, another consumer health player, yields similarly in the mid-2% range. HLN's payout ratio is conservative compared to higher-yield peers like KMB (around 55%), making it relatively attractive for yield-conscious investors seeking balanced growth and income in stable defensive sectors.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.

Is This Stock Attractive for Dividend Investors?

Haleon plc (HLN) suits conservative income investors prioritizing stability over high yields, given its defensive consumer health positioning and reliable semi-annual payouts. Those favoring dividend growth may appreciate the post-spin-off increases tied to earnings progression, though the brief history tempers expectations for aristocrat status. Long-term holders in staples sectors could value the low payout ratio and FCF coverage, offering resilience amid economic cycles. However, yield seekers might find richer options elsewhere, as HLN's 2% yield is modest. Balanced portfolios blending growth and income may benefit from its brand moats and leverage discipline, but volatility from currency (as a UK-based ADR) and sector dynamics warrants consideration. Overall, it fits patient investors comfortable with steady rather than spectacular returns.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations